Top Raleigh, NC Pharmaceutical Companies (37)
Don't see your company?
Create a company profile
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. We are powered by technology. Our Global Research Technologies, Medical Devices as a software, and Data Science teams are on the cutting edge of developing and supporting our life-saving medications.
Our purpose ensures that patients remain at the center of all we do. We live our purpose by sourcing the best science in the world; partnering with others in the healthcare system to improve access to our medicines; using digital technologies to enhance our drug discovery and development, as well as patient outcomes; and leading the conversation to advocate for pro-innovation/pro-patient policies.
Alphanumeric is leading life science and healthcare organizations toward a more efficient future - where patients and providers are met with personalized communication at every stage of their journey. Our teams are driven to improve and enhance interpersonal and patient experiences across industries. We provide more than call centers - we go beyond them to provide top-tier customer service, patient experience support, and HCP engagement that exceed expectations.
Founded in 1997, Ergomed is a global provider of high-quality services to the biopharmaceutical industry, spanning all phases of clinical trials, post-approval pharmacovigilance, and medical information. Ergomed’s fast-growing services business includes an industry-leading suite of specialist pharmacovigilance (PV) solutions, integrated under the PrimeVigilance brand, and Ergomed Clinical Research, a complete, global Phase I-IV clinical development and trial management services with a strong heritage in the development of drugs in rare diseases and oncology. • 1,400+ highly qualified professionals • Global full-service CRO • 25+ years of experience • Therapeutic specialization in oncology • Strong expertise in rare disease trials • Robust clinical safety system • Choice of leading drug safety databases Our key services include: • Clinical Research Services • Pharmacovigilance • Medical Information • Regulatory • Medical Writing • Site Management • Study Physician Support • Biostatistics • Patient Study Support
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI).
PCI is a pharmaceutical company specializing in calibration and data analysis services.
Performs research and development on innovative therapeutics for multiple rare and infectious diseases.
EternaTear is developing a next-generation therapy for the over-the-counter dry eye market.
About Worldwide Clinical Trials Worldwide Clinical Trials is a global, midsize contract research organization (CRO) that provides top-performing bioanalytical and Phase I-IV clinical development services to the biotechnology and pharmaceutical industries. Founded in 1986 by physicians committed to advancing medical science, our full-service clinical experience ranges from early phase and bioanalytical sciences through late phase studies, post approval, and real-world evidence. Major therapeutic areas of focus include cardiovascular, metabolic, neuroscience, oncology, and rare diseases. Operating in 60+ countries with offices in North and South America, Eastern and Western Europe, and Asia, Worldwide is powered by its more than 3,000 employee experts. For more information, please visit www.worldwide.com or connect with us on Twitter, LinkedIn, Facebook, and Instagram.
Accord Healthcare is a large-scale provider of generic pharmaceuticals in the United States. Our U.S. headquarters is in Durham, North Carolina, near the Research Triangle Park (RTP). Situated in a 7,000-acre pine forest, RTP is one of the largest research parks in the world. Close to three major research universities, the area provides an unparalleled scientific, regulatory, quality, and commercial talent pool. Accord is the commercial arm of Intas Pharmaceuticals, a pioneering biopharmaceutical company operating in India since 1976. Selling in over 75 countries, Accord has a vast global presence. The Accord and Intas networks provide full integration in the functional areas vital to delivering quality excellence and service efficiencies: API and finished dosage form manufacturing, R & D, clinical program management, and the economies of scale inherent in worldwide distribution. Accord is routinely cited in IQVIA presentations to industry as one of the fastest growing pharmaceutical companies in the U.S. Quarter-over-quarter, we consistently accomplish double-digit growth across all the metrics: in dollar sales, scripts filled, and number of units sold. We have accomplished this while undergoing multiple plant expansions across all of our manufacturing sites. Our solid record of maintaining high quality standards while implementing strategic commercial expansion has set us apart in the industry. Accord’s product offerings and pipeline demonstrate our commitment to meeting the needs of healthcare professionals and patients alike. We currently have approval for more than 115 ANDAs and are selling over 290 dosing presentations. We have 52 ANDAs pending at the FDA, and over 115 products in active development. Our pipeline spans a full range of dosage forms: orals, topicals, transdermal patches, liquid, lyophilized and complex injectables.
GeneBiology develops a patented new drugs for serious diseases using the 505(b)(2) regulatory pathway.
Clinical Solutions Group is a pharmaceutical company offering drug development services.
Dignify Therapeutics is a drug development company focused on delivering novel drug therapies for bladder and bowel disorders in spinal.
FLAG Therapeutics Inc., headquartered in Raleigh, North Carolina, is an early-stage oncology company.
Verinetics is introducing the DispenSecur solution for Opioid Medication Management. The only pharmaceutical supply chain friendly solution that provides Better Control for Controlled Substances.
At Merz Therapeutics, we seek to address the unique needs of people who suffer from movement disorders, neurological conditions, and other health conditions that severely impact patients’ quality of life. With our patient-centric approach, cutting-edge research and development efforts, highly-scientific medical affairs resources and dedicated commercial teams, we continue the advancement of new and individualized treatment standards, including botulinum toxin. Merz Therapeutics is headquartered in Frankfurt am Main, Germany and is represented in more than 90 countries, with a North America affiliate based in Raleigh, North Carolina. Merz Therapeutics GmbH is part of the Merz Group, a privately held, family-owned company that has dedicated more than 110 years to developing innovations that serve unmet patient and customer needs.
Erimos Pharmaceuticals is a biopharmaceutical company
With local operations in 132 countries, Stiefel is a global leader in the field of dermatology. Stiefel is renowned for its 165-year legacy of innovation in the field of skin health, utilizing a combination of expertise, enthusiasm and imagination to deliver the highest quality, most effective prescription and over-the-counter skin care products available. Stiefel, a GSK company social media channels: Twitter: http://twitter.com/stiefelagskco Facebook: http://www.facebook.com/StiefelGSK Stiefel Laboratories, Inc. was acquired by GlaxoSmithKline in July 2009. The acquisition has created a new world-leading specialist dermatology business. As part of the acquisition, Stiefel Laboratories is now called Stiefel, a GSK company.
G1 Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on the discovery, development and delivery of next generation therapies that improve the lives of those affected by cancer, including the Company’s first commercial product, COSELA™ (Trilaciclib). G1 has a deep clinical pipeline evaluating targeted cancer therapies in a variety of solid tumors, including colorectal, breast, lung, and bladder cancers, and is also advancing rintodestrant, a potential best-in-class oral selective estrogen receptor degrader, or SERD, for the treatment of ER+ breast cancer. In 2020, G1 out-licensed global development and commercialization rights to its differentiated oral CDK4/6 inhibitor, lerociclib. G1 Therapeutics is based in Research Triangle Park, N.C. For additional information, please visit www.g1therapeutics.com and follow us on Twitter @G1Therapeutics. View our social community guidelines here: https://www.g1therapeutics.com/social-guidelines
Tergus Pharma is an end-to-end service provider for topical pharmaceutical products supporting early phase research and formulation, drug development, testing, and both clinical and commercial manufacturing at our new 100,000 sq. ft. state-of-the-art facility in Durham, North Carolina. Tergus is the industry leader for topical/skin semi-solids and liquids as well as other non-skin semi-solids/liquids for vaginal, rectal and otic/ophthalmic routes of administration where we recognize the value of our stellar industry reputation for delivering quality results to clients. With industry-recognized leadership and expertise in method development, such as IVRT/IVPT for topical pharmaceuticals, Tergus also provides clients with peace of mind and helps them to de-risk their product development. Exclusively focused on topical development and manufacturing, Tergus brings the scientific expertise that helps our clients achieve the right balance of scientific knowhow, speed of results, and quality in product service, warranting our company motto, “Think Topicals, Think Tergus.
Work Your Passion. Live Your Purpose.
